• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞,癌症治疗的潜在靶点。

Tumor-associated macrophages, potential targets for cancer treatment.

作者信息

Yang Li, Zhang Yi

机构信息

Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Zhengzhou, Henan Province 450052 China.

School of Life Sciences, Zhengzhou University, No.100 Kexue Road, Zhengzhou, Henan Province 450001 China.

出版信息

Biomark Res. 2017 Aug 8;5:25. doi: 10.1186/s40364-017-0106-7. eCollection 2017.

DOI:10.1186/s40364-017-0106-7
PMID:28804638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5549387/
Abstract

The fact that various immune cells, including macrophages, can be found in tumor tissues has long been known. With the introduction of concept that macrophages differentiate into a classically or alternatively activated phenotype, the role of tumor-associated macrophages (TAMs) is now beginning to be elucidated. TAMs act as "protumoral macrophages", contributing to disease progression. As the relationship between TAMs and malignant tumors becomes clearer, TAMs are beginning to be seen as potential therapeutic targets in these cases. In this review, we will discuss how TAMs can be used as therapeutic targets of cancer in clinics.

摘要

长期以来,人们一直知道在肿瘤组织中可以发现包括巨噬细胞在内的各种免疫细胞。随着巨噬细胞可分化为经典激活或替代激活表型这一概念的引入,肿瘤相关巨噬细胞(TAM)的作用现在开始得到阐明。TAM作为“促肿瘤巨噬细胞”,促进疾病进展。随着TAM与恶性肿瘤之间的关系变得更加清晰,TAM在这些病例中开始被视为潜在的治疗靶点。在这篇综述中,我们将讨论TAM如何在临床上用作癌症的治疗靶点。

相似文献

1
Tumor-associated macrophages, potential targets for cancer treatment.肿瘤相关巨噬细胞,癌症治疗的潜在靶点。
Biomark Res. 2017 Aug 8;5:25. doi: 10.1186/s40364-017-0106-7. eCollection 2017.
2
Tumor-associated macrophages: from basic research to clinical application.肿瘤相关巨噬细胞:从基础研究到临床应用
J Hematol Oncol. 2017 Feb 28;10(1):58. doi: 10.1186/s13045-017-0430-2.
3
Clinical significance of macrophage heterogeneity in human malignant tumors.人类恶性肿瘤中巨噬细胞异质性的临床意义。
Cancer Sci. 2014 Jan;105(1):1-8. doi: 10.1111/cas.12314. Epub 2013 Nov 29.
4
Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy.头颈部癌症微环境中的巨噬细胞:癌症治疗的潜在靶点。
Oral Oncol. 2019 Jan;88:29-38. doi: 10.1016/j.oraloncology.2018.10.040. Epub 2018 Nov 20.
5
The role of tumor-associated macrophage in breast cancer biology.肿瘤相关巨噬细胞在乳腺癌生物学中的作用。
Histol Histopathol. 2018 Feb;33(2):133-145. doi: 10.14670/HH-11-916. Epub 2017 Jul 6.
6
Tumor-Associated Macrophages: A Potential Target for Cancer Therapy.肿瘤相关巨噬细胞:癌症治疗的潜在靶点。
Front Oncol. 2021 Jun 10;11:693517. doi: 10.3389/fonc.2021.693517. eCollection 2021.
7
Role of tumor-associated macrophages in hematological malignancies.肿瘤相关巨噬细胞在血液系统恶性肿瘤中的作用。
Pathol Int. 2015 Apr;65(4):170-6. doi: 10.1111/pin.12259. Epub 2015 Feb 23.
8
Tumor-Associated Macrophages as Target for Antitumor Therapy.肿瘤相关巨噬细胞作为抗肿瘤治疗的靶点。
Arch Immunol Ther Exp (Warsz). 2018 Apr;66(2):97-111. doi: 10.1007/s00005-017-0480-8. Epub 2017 Jun 28.
9
Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions.肿瘤相关巨噬细胞的 IL-4 替代激活:促进促肿瘤功能。
Cell Cycle. 2010 Dec 15;9(24):4824-35. doi: 10.4161/cc.9.24.14322.
10
Exploiting the cancer niche: Tumor-associated macrophages and hypoxia as promising synergistic targets for nano-based therapy.利用肿瘤微环境:肿瘤相关巨噬细胞和低氧作为基于纳米的治疗有前途的协同作用靶点。
J Control Release. 2017 May 10;253:82-96. doi: 10.1016/j.jconrel.2017.03.013. Epub 2017 Mar 8.

引用本文的文献

1
A glycogen derived from sea urchin- shifts macrophages to the M1 phenotype and enhances the anti-pancreatic cancer activity of gemcitabine.源自海胆的糖原可使巨噬细胞转变为M1表型,并增强吉西他滨的抗胰腺癌活性。
Front Pharmacol. 2025 Jul 25;16:1600349. doi: 10.3389/fphar.2025.1600349. eCollection 2025.
2
CAR T-cell immunotherapy as the next horizon in cancer eradication: current landscape, challenges, and future directions.嵌合抗原受体T细胞免疫疗法作为癌症根除的新希望:现状、挑战与未来方向
Med Oncol. 2025 Aug 6;42(9):410. doi: 10.1007/s12032-025-02957-1.
3
New insights on anti-tumor immunity of CD8 T cells: cancer stem cells, tumor immune microenvironment and immunotherapy.CD8 T细胞抗肿瘤免疫的新见解:癌症干细胞、肿瘤免疫微环境与免疫治疗
J Transl Med. 2025 Mar 17;23(1):341. doi: 10.1186/s12967-025-06291-y.
4
-Derived β-Glucan as a Novel Modulator of Tumor Microenvironment: Targeting Macrophage Polarization and Inducing Ferroptosis in Lung Cancer.来源于β-葡聚糖作为肿瘤微环境的新型调节剂:靶向巨噬细胞极化并诱导肺癌细胞铁死亡
J Inflamm Res. 2024 Dec 6;17:10479-10494. doi: 10.2147/JIR.S489191. eCollection 2024.
5
Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies.揭示肿瘤相关巨噬细胞在驱动上皮-间质转化中的作用:机制与治疗策略综述
Front Pharmacol. 2024 Sep 2;15:1404687. doi: 10.3389/fphar.2024.1404687. eCollection 2024.
6
The role of CD8 T-cells in colorectal cancer immunotherapy.CD8 T细胞在结直肠癌免疫治疗中的作用。
Heliyon. 2024 Jun 15;10(12):e33144. doi: 10.1016/j.heliyon.2024.e33144. eCollection 2024 Jun 30.
7
SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer.SPDYC 可作为与乳腺癌脂质代谢和免疫微环境相关的预后生物标志物。
Immunol Res. 2024 Oct;72(5):1030-1050. doi: 10.1007/s12026-024-09505-5. Epub 2024 Jun 18.
8
RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages.RUNX1通过调节肿瘤细胞与肿瘤相关巨噬细胞之间的相互作用促进结直肠癌血管生成。
Biomark Res. 2024 Feb 28;12(1):29. doi: 10.1186/s40364-024-00573-1.
9
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives.靶向Toll样受体7/8进行免疫治疗:最新进展与展望
Biomark Res. 2022 Dec 7;10(1):89. doi: 10.1186/s40364-022-00436-7.
10
Exosomal lncRNA HOTAIR induce macrophages to M2 polarization via PI3K/ p-AKT /AKT pathway and promote EMT and metastasis in laryngeal squamous cell carcinoma.外泌体长链非编码 RNA HOTAIR 通过 PI3K/ p-AKT / AKT 通路诱导巨噬细胞向 M2 极化,促进喉鳞状细胞癌的 EMT 和转移。
BMC Cancer. 2022 Nov 24;22(1):1208. doi: 10.1186/s12885-022-10210-5.

本文引用的文献

1
Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment.聚合物纳米颗粒促进肿瘤微环境中巨噬细胞从 M2 表型向 M1 表型的逆转。
Biomaterials. 2017 Jan;112:153-163. doi: 10.1016/j.biomaterials.2016.09.034. Epub 2016 Oct 4.
2
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.氧化铁纳米颗粒通过在肿瘤组织中诱导促炎型巨噬细胞极化来抑制肿瘤生长。
Nat Nanotechnol. 2016 Nov;11(11):986-994. doi: 10.1038/nnano.2016.168. Epub 2016 Sep 26.
3
Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.恶性胸腔积液中T细胞功能受损主要由巨噬细胞产生的转化生长因子-β(TGF-β)所致。
Int J Cancer. 2016 Nov 15;139(10):2261-9. doi: 10.1002/ijc.30289. Epub 2016 Aug 6.
4
Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives.曲贝替定治疗软组织肉瘤:现状与未来展望
Adv Ther. 2016 Jul;33(7):1055-71. doi: 10.1007/s12325-016-0344-3. Epub 2016 May 27.
5
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.在临界可切除和局部晚期胰腺癌患者中,使用CCR2抑制剂联合FOLFIRINOX靶向肿瘤相关巨噬细胞:一项单中心、开放标签、剂量探索、非随机的1b期试验。
Lancet Oncol. 2016 May;17(5):651-62. doi: 10.1016/S1470-2045(16)00078-4. Epub 2016 Apr 4.
6
A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer.一项关于Imprime PGG注射液联合西妥昔单抗治疗IV期KRAS突变型结直肠癌患者的II期疗效与安全性、开放标签、多中心研究。
Clin Colorectal Cancer. 2016 Sep;15(3):222-7. doi: 10.1016/j.clcc.2016.02.013. Epub 2016 Feb 13.
7
Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.生物共轭二氧化锰纳米颗粒通过使肿瘤相关巨噬细胞向M1样表型极化并减轻肿瘤缺氧来增强化疗反应。
ACS Nano. 2016 Jan 26;10(1):633-647. doi: 10.1021/acsnano.5b06779. Epub 2015 Dec 14.
8
Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 "Don't Eat Me" Signals.分子途径:通过阻断CD47“别吃我”信号,在癌细胞吞噬后激活T细胞
Clin Cancer Res. 2015 Aug 15;21(16):3597-601. doi: 10.1158/1078-0432.CCR-14-2520. Epub 2015 Jun 26.
9
CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.CD163+肿瘤相关巨噬细胞是一种预后生物标志物,且与肺癌患者恶性胸腔积液的治疗效果相关。
Oncotarget. 2015 Apr 30;6(12):10592-603. doi: 10.18632/oncotarget.3547.
10
Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study.激动型抗 CD40 抗体的临床和生物学效应:英国癌症研究所的 I 期研究。
Clin Cancer Res. 2015 Mar 15;21(6):1321-8. doi: 10.1158/1078-0432.CCR-14-2355. Epub 2015 Jan 14.